DM2 and HFrEF Patient Case Review
CorConsult Rx: Evidence-Based Medicine and Pharmacy · Mike Corvino, PharmD, BCPS, CDE and Cole Swanson, PharmD
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This episode was originally supposed to be a simple topic discussion between my student and me. We ended up recording it as a podcast episode that will hopefully serve as a quick review of material that has been covered in other episodes.
The patient case that we discussed during the episode:
63 y/o female with diabetes, HFrEF, hypertension.
Medications:
A1c = 8.9%
HFrEF – EF = 30%
BP = 154/84 mmHg
Glargine-Lantus insulin 36 U QAM
Pioglitazone 45 mg
Lisinopril 10 mg
HCTZ 25 mg QAM
Metoprolol tartrate 50 mg BID
Carvedilol 25mg BID
Doxazosin 4 mg daily èSTOP
Simvastatin 20 mg
She presents for pharmacotherapy management
If you have any questions, reach out to us on any of the following:
Mike - [email protected] Cole - [email protected]
Instagram and other social media platforms - @corconsultrx
This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.